Xconomy Boston

Avila Therapeutics Receives $30,000,000 Series B Financing

  • Feed Type
  • Date
    7/27/2009
  • Company Name
    Avila Therapeutics
  • Mailing Address
    100 Beaver Street Waltham, MA 02453
  • Company Description
    Avila Therapeutics, Inc., is a venture-backed company focused on the discovery and development of novel small molecule therapeutics to address significant unmet clinical needs with an initial focus on cancer and viral diseases.
  • Website
    http://www.avilatx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The new financing will be used to move Avila’s first program into clinical trials, while also advancing the Avilomics drug discovery approach, the company said.
  • M&A Terms
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Advent Venture Partners
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Polaris Venture Partners

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.